Skip to main content

Ocular Therapeutix Downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright analyst Yi Chen downgraded Ocular Therapeutix to Neutral from Buy without a price target. The analyst cites valuation and "near-term market uncertainty" for the downgrade.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.